Personalized and Stratified Therapy in Epilepsy

Authors

Sara Eyal Institute for Drug Research, School of Pharmacy Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Dr. Eyal is a senior lecturer at the HUJI Institute for Drug Research since 2011. Her research is aimed at better understanding of the factors that affect drug distribution across the blood-brain barrier (BBB), introducing novel markers for studying molecular changes at the BBB itself and developing delivery systems which would be able to overcome the anatomical and functional barriers to the CNS. In particular, she focuses on identification and targeting epileptogenic brain tissue. She has published more than 50 papers, is on the Editorial Board of Frontiers in Pharmacology; Drug Transport and Metabolism, and recently edited a special issue of Pharmaceutical Research on drug treatment in pregnant and breastfeeding women. Dr. Eyal is a member of the Steering Committee of the Israeli League against Epilepsy. Dana Ekstein Director, Epilepsy Unit, Department of Neurology, Hadassah Medical Centre, Israel. Dr. Ekstein is the Director of the Epilepsy Unit in the Department of Neurology at Hadassah Medical Centre. She is an adult epileptologist, familiar with all aspects of patients care, including pharmacotherapy, surgical treatment, psychosocial issues, and imaging and electrophysiological studies. As part of the PhD and following basic research, she has also expertise in animal models of epilepsy, translational research on epileptic tissue identification, and rodents and human electrophysiology. She is the author of more than 30 original and review papers and several book chapters, and ad-hoc reviewer for several epilepsy journals. Dr. Ekstein is the head of the Epilepsy Unit at Hadassah Medical Center, Israel, and head of the Israeli Chapter of the ILAE.